Showing results (51-60 of 178) with videos related to

Sort By:
Pageof 18
Journal of Gastroenterology and Hepatology|June 30, 2016
Long-term outcome of surgical resection for intraductal papillary neoplasm of the bile ductVor Luvira, Ake Pugkhem, Vajarabhongsa Bhudhisawasdi, et al.
Cancer|September 26, 2003
Prognostic value of serum MUC5AC mucin in patients with cholangiocarcinomaChanchai Boonla, Sopit Wongkham, John Kieran Sheehan, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|December 6, 2017
Papillomatosis of the Biliary Tree and Gallbladder: Successful Treatment With Repeated Resection and Liver TransplantVor Luvira, Ake Pugkhem, Vajarabhongsa Bhudhisawasdi, et al.
Parasitology|April 29, 2022
Adherence of Helicobacter pylori to Opisthorchis viverrini gut epithelium and the tegument mediated via L-fucose binding adhesinPrissadee Thanaphongdecha, Yaovalux Chamgramol, Chawalit Pairojkul, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|March 17, 2015
The carcinogenic liver fluke Opisthorchis viverrini is a reservoir for species of HelicobacterRaksawan Deenonpoe, Chariya Chomvarin, Chawalit Pairojkul, et al.
Human Pathology|May 16, 2022
Chromosomal aberrations, visualized using UroVysion® fluorescence in-situ hybridization assay, can predict poor prognosis in formalin-fixed paraffin-embedded tissues of cholangiocarcinoma patientsSudarat Ainthachot, Prakasit Sa-Ngiamwibool, Malinee Thanee, et al.
International Journal of Oncology|June 28, 2012
Periostin activates integrin α5β1 through a PI3K/AKT‑dependent pathway in invasion of cholangiocarcinomaKusumawadee Utispan, Jumaporn Sonongbua, Peti Thuwajit, et al.
Cancer Letters|December 25, 2004
Promoter hypermethylation is a major event of hMLH1 gene inactivation in liver fluke related cholangiocarcinomaTemduang Limpaiboon, Prasong Khaenam, Patcharee Chinnasri, et al.
Human Pathology|March 27, 2012
Prognostic significance of peroxiredoxin 1 and ezrin-radixin-moesin-binding phosphoprotein 50 in cholangiocarcinomaPonlapat Yonglitthipagon, Chawalit Pairojkul, Yaovalux Chamgramol, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|July 22, 2014
STATs profiling reveals predominantly-activated STAT3 in cholangiocarcinoma genesis and progressionHasaya Dokduang, Anchalee Techasen, Nisana Namwat, et al.
Pageof 18